Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications
Authorized Users Only
2017
Authors
Šefer, DijanaBižić-Radulović, Sandra
Kraguljac-Kurtović, Nada
Bogdanović, Andrija

Čokić, Vladan

Miljić, Predrag
Beleslin-Čokić, Bojana
Knežević, Vesna
Mitrović-Ajtić, Olivera

Leković, Danijela

Gotić, Mirjana
Article (Published version)

Metadata
Show full item recordAbstract
Introduction: Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are characterized by overproduction of one or more blood cell lines. Methods: We studied the proliferative characteristics of 91 patients with de novo Ph-MPN. Colony-forming cells (CFC) and endogenous colonies (EC), from bone marrow (BM) and/or peripheral blood (PB), were analyzed by colony assay based on methylcellulose. The level of circulating CD34(+) cells was determined by flow cytometry. Results: The total number of PB CFC in primary myelofibrosis (PMF) was increased compared to the control sample (P lt 0.01) and essential thrombocythemia (ET) (P lt 0.05). The highest number of BM and PB EC was observed in polycythemia vera (PV) (P lt 0.01). Increased levels of CD34(+) cells characterized early-prefibrotic (57%) and advanced-fibrotic PMF (90%) as compared to PV (34%) and ET (32%) (P lt 0.01). In the whole Ph-MPN group, the total number of PB CFC (P lt 0.01), PB EC (P lt 0.05), and CD34+ cells (P... lt 0.01) correlated with the degree of BM fibrosis. Higher levels of circulating CD34(+) cells in PMF correlated with the total number of PB EC (P lt 0.05) and degree of BM fibrosis (P lt 0.01). Conclusions: Exploration of the PB proliferative characteristics of Ph-MPN on diagnosis may be helpful in revealing early-prefibrotic PMF. Monitoring the levels of circulating CD34(+) cells may provide a sensitive indicator of fibrotic evolution in PV and PMF.
Keywords:
Myeloproliferative neoplasm / colony-forming cells / endogenous colonies / CD34(+) cells / JAK2V617FSource:
International Journal of Laboratory Hematology, 2017, 39, 1, 21-31Publisher:
- Wiley, Hoboken
Funding / projects:
DOI: 10.1111/ijlh.12564
ISSN: 1751-5521
PubMed: 28025866
WoS: 000393893300011
Scopus: 2-s2.0-85007319780
Collections
Institution/Community
Institut za medicinska istraživanjaTY - JOUR AU - Šefer, Dijana AU - Bižić-Radulović, Sandra AU - Kraguljac-Kurtović, Nada AU - Bogdanović, Andrija AU - Čokić, Vladan AU - Miljić, Predrag AU - Beleslin-Čokić, Bojana AU - Knežević, Vesna AU - Mitrović-Ajtić, Olivera AU - Leković, Danijela AU - Gotić, Mirjana PY - 2017 UR - http://rimi.imi.bg.ac.rs/handle/123456789/795 AB - Introduction: Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are characterized by overproduction of one or more blood cell lines. Methods: We studied the proliferative characteristics of 91 patients with de novo Ph-MPN. Colony-forming cells (CFC) and endogenous colonies (EC), from bone marrow (BM) and/or peripheral blood (PB), were analyzed by colony assay based on methylcellulose. The level of circulating CD34(+) cells was determined by flow cytometry. Results: The total number of PB CFC in primary myelofibrosis (PMF) was increased compared to the control sample (P lt 0.01) and essential thrombocythemia (ET) (P lt 0.05). The highest number of BM and PB EC was observed in polycythemia vera (PV) (P lt 0.01). Increased levels of CD34(+) cells characterized early-prefibrotic (57%) and advanced-fibrotic PMF (90%) as compared to PV (34%) and ET (32%) (P lt 0.01). In the whole Ph-MPN group, the total number of PB CFC (P lt 0.01), PB EC (P lt 0.05), and CD34+ cells (P lt 0.01) correlated with the degree of BM fibrosis. Higher levels of circulating CD34(+) cells in PMF correlated with the total number of PB EC (P lt 0.05) and degree of BM fibrosis (P lt 0.01). Conclusions: Exploration of the PB proliferative characteristics of Ph-MPN on diagnosis may be helpful in revealing early-prefibrotic PMF. Monitoring the levels of circulating CD34(+) cells may provide a sensitive indicator of fibrotic evolution in PV and PMF. PB - Wiley, Hoboken T2 - International Journal of Laboratory Hematology T1 - Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications EP - 31 IS - 1 SP - 21 VL - 39 DO - 10.1111/ijlh.12564 UR - conv_3964 ER -
@article{ author = "Šefer, Dijana and Bižić-Radulović, Sandra and Kraguljac-Kurtović, Nada and Bogdanović, Andrija and Čokić, Vladan and Miljić, Predrag and Beleslin-Čokić, Bojana and Knežević, Vesna and Mitrović-Ajtić, Olivera and Leković, Danijela and Gotić, Mirjana", year = "2017", abstract = "Introduction: Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are characterized by overproduction of one or more blood cell lines. Methods: We studied the proliferative characteristics of 91 patients with de novo Ph-MPN. Colony-forming cells (CFC) and endogenous colonies (EC), from bone marrow (BM) and/or peripheral blood (PB), were analyzed by colony assay based on methylcellulose. The level of circulating CD34(+) cells was determined by flow cytometry. Results: The total number of PB CFC in primary myelofibrosis (PMF) was increased compared to the control sample (P lt 0.01) and essential thrombocythemia (ET) (P lt 0.05). The highest number of BM and PB EC was observed in polycythemia vera (PV) (P lt 0.01). Increased levels of CD34(+) cells characterized early-prefibrotic (57%) and advanced-fibrotic PMF (90%) as compared to PV (34%) and ET (32%) (P lt 0.01). In the whole Ph-MPN group, the total number of PB CFC (P lt 0.01), PB EC (P lt 0.05), and CD34+ cells (P lt 0.01) correlated with the degree of BM fibrosis. Higher levels of circulating CD34(+) cells in PMF correlated with the total number of PB EC (P lt 0.05) and degree of BM fibrosis (P lt 0.01). Conclusions: Exploration of the PB proliferative characteristics of Ph-MPN on diagnosis may be helpful in revealing early-prefibrotic PMF. Monitoring the levels of circulating CD34(+) cells may provide a sensitive indicator of fibrotic evolution in PV and PMF.", publisher = "Wiley, Hoboken", journal = "International Journal of Laboratory Hematology", title = "Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications", pages = "31-21", number = "1", volume = "39", doi = "10.1111/ijlh.12564", url = "conv_3964" }
Šefer, D., Bižić-Radulović, S., Kraguljac-Kurtović, N., Bogdanović, A., Čokić, V., Miljić, P., Beleslin-Čokić, B., Knežević, V., Mitrović-Ajtić, O., Leković, D.,& Gotić, M.. (2017). Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications. in International Journal of Laboratory Hematology Wiley, Hoboken., 39(1), 21-31. https://doi.org/10.1111/ijlh.12564 conv_3964
Šefer D, Bižić-Radulović S, Kraguljac-Kurtović N, Bogdanović A, Čokić V, Miljić P, Beleslin-Čokić B, Knežević V, Mitrović-Ajtić O, Leković D, Gotić M. Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications. in International Journal of Laboratory Hematology. 2017;39(1):21-31. doi:10.1111/ijlh.12564 conv_3964 .
Šefer, Dijana, Bižić-Radulović, Sandra, Kraguljac-Kurtović, Nada, Bogdanović, Andrija, Čokić, Vladan, Miljić, Predrag, Beleslin-Čokić, Bojana, Knežević, Vesna, Mitrović-Ajtić, Olivera, Leković, Danijela, Gotić, Mirjana, "Proliferative characteristics of Philadelphia-negative myeloproliferative neoplasms - clinical implications" in International Journal of Laboratory Hematology, 39, no. 1 (2017):21-31, https://doi.org/10.1111/ijlh.12564 ., conv_3964 .